Full Professor
Strategic program(s):
Biography
Linde Meyaard obtained her PhD in 1995 (cum laude) at Sanquin in Amsterdam studying mechanism of immune dysfunction in HIV infection. In 1996 she entered the immune inhibitory receptor field as a post-doc at DNAX Research Institute in California. She identified a novel inhibitory immune receptor, LAIR-1, and continued her work on this receptor in as a fellow of the Royal Academy of Sciences (KNAW) in the UMC Utrecht.
Since 2000 she leads her own research group embedded in the Center Translational Immunology, supported by multiple grants such as the NWO Vidi and Vici. Meyaard was the first to identify collagens and collagen-like proteins as the natural ligands for LAIR-1. She then extended her research towards other inhibitory receptors and studies these inhibitory receptors in...
Research aim
To use the full potential of inhibitory receptors to cure inflammatory disease and cancer
Go to group1999-2001 Fellow of the Royal Dutch Academy of Science (KNAW)
2001 NWO Vidi
2002 NWO Aspasia
2014 NWO Vici
Consultant - Consulteren op het gebied van immunology - AbbVie
Member of the review committee - review public-private funding (PPS) submissions - Dutch Cancer Society (KWF)
Investigator - dezelfde werkzaamheden als huidige functie - Oncode
Collaborative research agreement - Ik werk samen...